Strauss Troy Investigates DePuy Hip Replacements

Strauss Troy is currently evaluating cases involving Johnson and Johnson’s DePuy hip replacements. While Johnson and Johnson promoted the DePuy “metal-on-metal” hip replacements as lasting longer than similar devices that included ceramic or plastic materials, the truth was exactly the opposite. In fact, the five-year failure rate on some of the DePuy hips is close …Read More

Strauss Troy Investigates Companies Purchasing Annuities for Violation of Interest Rate Statutes

Strauss Troy is investigating companies that purchase structured settlement annuities and retirement annuities. These purchases result an individual receiving a lump sum of money in exchange for giving up a stream of payments from an annuity. Individuals typically come to receive payments from an annuity either because they have entered into a structured settlement as …Read More

Strauss Troy Files Lawsuit Alleging Bayer’s Prescription Drug Xarelto® Causes Internal Bleeding

Strauss Troy Files Lawsuit Alleging GlaxoSmithKline’s Prescription Drug Zofran® Causes Birth Defects

Strauss Troy Co. has filed a civil lawsuit in federal court in the Southern District of Ohio against Bayer, manufacturer of the drug Xarelto®, and Janssen Pharmacefuticals (a subsidiary of Johnson & Johnson that marketed the drug in the U.S.). Xarelto (generic name rivaroxaban) is generally referred to as a blood thinner. It is prescribed …Read More

Strauss Troy Files Class Action Lawsuit Against Cognizant Technology Solutions Corporation

On October  27th, 2016, Strauss Troy filed a class action lawsuit on behalf of all purchasers of Cognizant Technology Solutions Corporation (“Cognizant” or the “Company”) (NASDAQ: CTSH).  The Complaint was filed in the United States District Court for the District of New Jersey on behalf of investors who purchased shares in Cognizant during the period …Read More

Strauss Troy Presents Two CLE Seminars On November 15

As part of Strauss Troy’s Professional Development Series, the firm will present TWO in-house seminars on Tuesday, November 15, 2016 beginning at 8 a.m. for registration, with the first program beginning at 8:15 am. The first presentation is titled, “Small Business Law Conference” and qualifies for 6.0 general hours of CLE credit.  The topics include: …Read More

Defamation Statute of Limitations: Act Quickly, Before It’s Too Late

In today’s media-saturated world, where the power of the internet can bring global attention in an instant, the threat of unfair criticism is ever present. But when criticism is based on a false statement, that can cross the line into unlawful defamation. The law can protect you if you are the victim of defamation, but …Read More

On Social Media, Legal Risks Go Viral

  Social media has become an integral part of our personal and professional lives. It is nearly impossible to find an individual or organization without a corresponding Facebook, Twitter, LinkedIn, Instagram or Snapchat account. While the benefits of social media are readily apparent, the legal risks that accompany it are often overlooked. At the touch …Read More